 |
|
Streptococcus mitis EndocarditisReport of 17 Cases
Kevin B. Rapeport, MBBCh(Rand);
José A. Girón, MD;
Fred Rosner, MD
Arch Intern Med. 1986;146(12):2361-2363.
Abstract
• Seventeen patients with Streptococcus mitis endocarditis were treated at a municipal hospital over a three-year period. Thirteen patients were intravenous drug addicts. Streptococcus mitis has a predilection for right-sided endocarditis in intravenous drug addicts and left-sided endocarditis in non-drug addicts. Streptococcus mitis is highly susceptible to therapy with penicillin G potassium (minimal inhibitory concentration less than or equal to 0.1 mg/L of penicillin in all of these 17 cases), and four to six weeks of therapy is safe and effective.
(Arch Intern Med 1986;146:2361-2363)
Author Affiliations
From the Division of Cardiology, Lenox Hill Hospital, New York (Dr Rapeport); the Division of Infectious Diseases (Dr Girón) and the Department of Medicine (Dr Rosner), Queens Hospital Center Affiliation of the Long Island Jewish Medical Center, Jamaica, NY; and the School of Medicine, Health Sciences Center, State University of New York at Stony Brook (Drs Girón and Rosner).
Footnotes
Accepted for publication March 31, 1986.
Reprint requests to Division of Cardiology, Lenox Hill Hospital, 100 E 77th St, New York, NY 10021 (Dr Rapeport).
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati  Twitter
What's this?
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
Infective Endocarditis: Diagnosis, Antimicrobial Therapy, and Management of Complications: A Statement for Healthcare Professionals From the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, and the Councils on Clinical Cardiology, Stroke, and Cardiovascular Surgery and Anesthesia, American Heart Association: Endorsed by the Infectious Diseases Society of America
Baddour et al.
Circulation 2005;111:e394-e434.
ABSTRACT
| FULL TEXT
|
